Atlas Trials

A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C

Clinical trial NCT01482403 · COMPLETED

Trial details

NCT number
NCT01482403
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatitis C, Chronic
Start date
2011-11-01
Primary completion
2014-01-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.